Cheryl M Corcoran,
David Kimhy,
Arielle Stanford,
Shamir Khan, Julie Walsh,
Judy Thompson,
Scott Schobel,
Jill Harkavy-Friedman,
Ray Goetz,
Tiziano Colibazzi,
Victoria Cressman,
Dolores Malaspina
[show abstract]
[hide abstract]
ABSTRACT: Cannabis use is reported to increase the risk for psychosis, but no prospective study has longitudinally examined drug use and symptoms concurrently in clinical high risk cases.
We prospectively followed for up to 2 years 32 cases who met research criteria for prodromal psychosis to examine the relationship between substance use and clinical measures.
Cases with a baseline history of cannabis use (41%) were older, but did not differ in clinical measures. Longitudinal assessments showed these cases had significantly more perceptual disturbances and worse functioning during epochs of increased cannabis use that were unexplained by concurrent use of other drugs or medications.
These data demonstrate that cannabis use may be a risk factor for the exacerbation of subthreshold psychotic symptoms, specifically perceptual disturbances, in high risk cases.
Schizophrenia Research 10/2008; 106(2-3):286-93. · 4.75 Impact Factor
